Notification for retail price fixation of 2 new drugs launched without prior price approval

REGD. No. D. L.-33004/99 The Gazette of India CG-DL-E-27082026-275828 EXTRAORDINARY PART II-Section 3-Sub-section (ii) PUBLISHED BY AUTHORITY No. 4590] NEW DELHI, THURSDAY, AUGUST 27, 2026/BHADRA 5, 1948 2 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II-SEC. 3(ii)] MINISTRY OF CHEMICALS AND FERTILIZERS (Department of Pharmaceuticals) (NATIONAL PHARMACEUTICAL PRICING AUTHORITY) ORDER New Delhi, the 27th August, 2026 S.O. 4775(E). In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013, S.O. 5249(E) dated 11th November, 2022 and S.O. 3516(E) dated 30th June, 2026 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof; TABLE +-----+-----------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+----------------+ | SI. | Name of the | Strength | Unit | Manufacturer & Marketing | Retail | | No. | Formulation / Brand | | | Company | Price | | | Name | | | | (Rs.) | +=====+===================================+=================================================================================================================================================================+===========+==============================================+================+ | (1) | (2) | (3) | (4) | (5) | (6) | +-----+-----------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+----------------+ | 1 | Donepezil and | Each film coated tablet contains: | 1 Tablet | M/s Cipla Limited | 12.31 | | | Memantine Tablets | Donepezil Hydrochloride 5mg | | | | | | | Memantine Hydrochloride 10mg | | | | +-----+-----------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+----------------+ | 2 | Rabeprazole sodium and | Each hard gelatin capsule contains: | 1 Capsule | M/s. Ved Lifesavers (P) Ltd./ | 7.47 | | | Domperidone Capsules | Rabeprazole Sodium IP 20 mg (As | | M/s German Remedies | | | | | Enteric Coated Pellets), Domperidone | | Pharmaceuticals Private | | | | | IP 30mg (As Sustained Release | | Limited | | | | | Pellets) | | | | +-----+-----------------------------------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+----------------+ Notes: (a) The manufacturer, as mentioned in column (5) of the table above, of formulations i.e., "new drug" under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price not exceeding the price as specified in column (6) of the table above. (b) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies. (c) The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table. (d) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form-V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers. (e) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same. (f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955. [PN/282/150/2026/F/F. No. 8(150)/2026/D.P./NPPA-Div.-II] BHIVA RAM YADAV, Assistant Director Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi-110064 and Published by the Controller of Publications, Delhi-110054.